Refine by
Biomark Equipment Supplied In Usa Utah
7 equipment items found
by:Magellan Bioanalytics, Inc. based inSalt Lake City, UTAH (USA)
We’re Changing What's Possible in Mass Spec Research. Magellan designs software for analysis of large biomolecular datasets, particularly those derived from mass spectrometry. With technological leaps in mass-spec instrumentation, Magellan’s software provides the computational tools to rapidly analyze massive mass-spec data flows. Magellan’s analytics can consider the entire ...
Manufactured by:Quansys Biosciences Inc. based inLogan, UTAH (USA)
The Q-Plex Human Chemokine (4-Plex) is a fully quantitative ELISA-based chemiluminescent assay allowing concurrent measurement of four biomarkers or analytes (IL-8, IP-10, MCP-1, Rantes). Each kit contains a 96-well plate, with each well featuring the relevant biomarker panel, and all the reagents required to perform testing. Q-Plex plates are built by absorbing ...
Manufactured by:Quansys Biosciences Inc. based inLogan, UTAH (USA)
The Q-Plex Mouse Cytokine Inflammation HS (14-Plex) is a fully quantitative ELISA-based chemiluminescent assay allowing the concurrent measurement of 14 biomarkers or analytes. Using just 25 µL of sample per well, up to 80 samples can be assayed for all 14 markers in the panel within 5.5 hours. The Q-Plex Mouse Cytokine Inflammation HS (14-Plex) provides researchers an easy ...
Manufactured by:Quansys Biosciences Inc. based inLogan, UTAH (USA)
The Q-Plex Mouse Cytokine Screen HS Stripwells (16-Plex) is a fully quantitative ELISA-based chemiluminescent assay allowing the concurrent measurement of 16 biomarkers or analytes. Using just 25 µL of sample per well, up to 80 samples can be assayed for all 16 markers in the panel within 5.5 hours. The Q-Plex Mouse Cytokine Screen HS Stripwells ...
Manufactured by:Quansys Biosciences Inc. based inLogan, UTAH (USA)
The Q-Plex Human Angiogenesis (9-Plex) is a fully quantitative ELISA-based chemiluminescent assay allowing the concurrent measurement of nine biomarkers or analytes. Using only 25 µL of sample per well, up to 80 samples can be assayed for all nine markers in the panel within 2.25 hours. The Q-Plex Human Angiogenesis (9-Plex) provides researchers an easy to use and cost ...
by:Sumitomo Pharma Oncology, Inc. based inCambridge, MASSACHUSETTS (USA)
TP-1287 is an investigational oral CDK9 inhibitor that has shown favorable oral bioavailability in preclinical models. TP-1287 is enzymatically cleaved, yielding the active moiety, a potent inhibitor of CDK9.35 Inhibiting CDK9 is thought to downregulate the transcription of target genes, including MCL-1, reducing leukemic blast viability in MCL-1–dependent hematologic malignancies, and ...
by:Sumitomo Pharma Oncology, Inc. based inCambridge, MASSACHUSETTS (USA)
TP-3654 is an oral investigational inhibitor of PIM kinases, which has potential antitumor and anti-fibrotic effects through multiple pathways, including induction of ...